chr1-16022959-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_004070.4(CLCNKA):​c.100+240T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0112 in 152,324 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.011 ( 11 hom., cov: 33)

Consequence

CLCNKA
NM_004070.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.02

Publications

0 publications found
Variant links:
Genes affected
CLCNKA (HGNC:2026): (chloride voltage-gated channel Ka) This gene is a member of the CLC family of voltage-gated chloride channels. The encoded protein is predicted to have 12 transmembrane domains, and requires a beta subunit called barttin to form a functional channel. It is thought to function in salt reabsorption in the kidney and potassium recycling in the inner ear. The gene is highly similar to CLCNKB, which is located 10 kb downstream from this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CLCNKA Gene-Disease associations (from GenCC):
  • Bartter disease type 4B
    Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 1-16022959-T-C is Benign according to our data. Variant chr1-16022959-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 1318226.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0112 (1713/152324) while in subpopulation SAS AF = 0.0363 (175/4818). AF 95% confidence interval is 0.0319. There are 11 homozygotes in GnomAd4. There are 853 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 Unknown,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCNKANM_004070.4 linkc.100+240T>C intron_variant Intron 2 of 19 ENST00000331433.5 NP_004061.3 P51800-1
CLCNKANM_001042704.2 linkc.100+240T>C intron_variant Intron 2 of 19 NP_001036169.1 P51800-3
CLCNKANM_001257139.2 linkc.100+240T>C intron_variant Intron 2 of 18 NP_001244068.1 P51800-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCNKAENST00000331433.5 linkc.100+240T>C intron_variant Intron 2 of 19 1 NM_004070.4 ENSP00000332771.4 P51800-1

Frequencies

GnomAD3 genomes
AF:
0.0112
AC:
1709
AN:
152206
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00275
Gnomad AMI
AF:
0.0680
Gnomad AMR
AF:
0.00615
Gnomad ASJ
AF:
0.0176
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0359
Gnomad FIN
AF:
0.00574
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0163
Gnomad OTH
AF:
0.0110
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0112
AC:
1713
AN:
152324
Hom.:
11
Cov.:
33
AF XY:
0.0115
AC XY:
853
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00274
AC:
114
AN:
41580
American (AMR)
AF:
0.00614
AC:
94
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
61
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.0363
AC:
175
AN:
4818
European-Finnish (FIN)
AF:
0.00574
AC:
61
AN:
10628
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0164
AC:
1113
AN:
68022
Other (OTH)
AF:
0.0109
AC:
23
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
90
179
269
358
448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0129
Hom.:
1
Bravo
AF:
0.0102
Asia WGS
AF:
0.0100
AC:
36
AN:
3476

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Feb 13, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.47
DANN
Benign
0.64
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111821117; hg19: chr1-16349454; API